Clinical Trials in Baltimore

Showing 20861-20880 of 23,476 trials

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00003967

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of topotecan plus etoposide in treating patients who have recurrent ovarian cancer, peritoneal cancer, or fallopian tube cancer.

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Gynecologic Oncology Group24 participantsStarted Sep 1999

Iowa City, Iowa, United States • Baltimore, Maryland, United States • Camden, New Jersey, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

NCT00943072

This is a phase 3 study to determine the efficacy of VEGF Trap-Eye injected into the eye on vision function in subjects with macular edema as a consequence of central retinal vein occlusion.

Macular Edema Secondary to Central Retinal Vein Occlusion

Regeneron Pharmaceuticals189 participantsStarted Jul 2009

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +58 more locations

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Find Trials by Condition in Baltimore

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

A Study of Family-based Cognitive-behavioral Therapy for Chronic Pediatric Headache and Anxiety

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

Safety and Tolerability of STP206 in Healthy Adult Subjects

A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Pilonidal Disease Wound Healing Study

Stepped Care in the Treatment of Trichotillomania

Quality of Life in Survivors of Gynecologic Cancer

Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Adults on Antibiotics

Sorafenib/Docetaxel Dose Escalation Trial

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)